http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3948270-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e6c9a4e9a7ab0cd23b3adabfddda094 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-60 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 |
| filingDate | 2020-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1197a182e7b01adfc90b52230bd35377 |
| publicationDate | 2022-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-3948270-A1 |
| titleOfInvention | Biorelevant composition |
| abstract | A biorelevant precursor composition suitable, upon dispersing, dilution or suspension in an aqueous medium, for simulating fed-state gastric fluids of mammalian species, wherein said biorelevant precursor composition comprises a substantially solid/solid- like concentrate, a viscous gel-like concentrate, or a liquid fat dispersion/concentrate, comprising at least one primary component selected from each of the following groups of primary components comprising: i) Triglyceride and/or diglyceride and/or monoglyceride or any combinations thereof in an amount of from 1 - 70% by weight; ii) Lecithin and/or lysolecithin in an amount of from 1 - 45% by weight; iii) Carbohydrate in an amount of from 15 - 70% by weight; and iv) Water or other aqueous medium in an amount of from 1 - 70% by weight; wherein the weight ratio of total fats (one or more primary components from each of groups i) and ii) combined) : total carbohydrates (one or more primary components from group iii) combined) is between 20:1 to 1:20; and the weight ratio of glyceride : lecithin and/or lysolecithin is between 45:1 and 1:45; and in addition at least one additional component selected from at least one of the following: (i) fatty acids (between 0.01 - 15% by weight); (ii) bile acid/salt (between 0.01 - 3% by weight); (iii) enzymes (between 0.01 - 2% by weight); (iv) cholesterol, sterols (between 0.01 - 5% by weight); (v) buffer agents (between 0.01 - 4% by weight); (vi) osmotic agents (between 0.01 - 10% by weight); 52 (vii) proteins (collagen, protein hydrolysates, amino acids) (between 0.01 - 30% by weight); (viii) mucin (between 0.1 - 5% by weight); (ix) viscosity modifier (between 0.1 - 5% by weight); and (x) preservatives, stabilizers (between 0.01 - 3% by weight), such as a) anti-oxidants, b) chelating agents, c) buffers (inorganic or organic), and d) antimicrobials; all percentages being by dry weight. A method of producing these compositions is also provided. |
| priorityDate | 2019-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 207.